News
20h
Zacks Investment Research on MSNHere's How Lilly's Non-Obesity Drugs are Contributing to Sales GrowthWhile Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...
2don MSN
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
7d
Zacks Investment Research on MSNCan LLY's Next-Generation Obesity Pipeline Fuel Further Growth?Eli Lilly LLY has experienced significant growth in the past few years, particularly driven by the success of its popular ...
Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announc ...
Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...
As Wall Street puts April's tariff shakeout in the rearview mirror and indexes set record highs, investors remain wary of U.S ...
Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...
Their most recent survey was conducted June 12 and 13, the first and second days of Israel’s strikes on Iran. Like previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results